RMTI Turned the Corner RMTI has everything you want in a questionable stock market. A Chart patter then bottomed with classic Head and Shoulder pattern and a break out. the company has multiple years delivering what they promised and forecast. And they are in a industry not controlled by the economy; a manufacturer of
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.03 USD
−480.00 K USD
101.49 M USD
29.52 M
About Rockwell Medical, Inc.
Sector
Industry
CEO
Mark Strobeck
Website
Headquarters
Wixom
Founded
1996
FIGI
BBG000BMC004
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.
Rockwell Medical RMTIThis is a turn around story.
New management changed the direction of how they did things and 2nd quarter earnings just released was recognition that they are on the right path.
The chart tells the whole story and head and shoulder bottom and break out. Rockwell is a microcap manufacturer of hem
Rockwell MedicaL - RMTIRockwell Medical RMTI has just completed a bottom bowl that started 11 months ago. The first Qtr. 2024 was the first profit improvement and the chart display strength with that Quarterly report.
The MACD bottomed in August 2023 and has risen and continues to send strength sikgnals.
The new
Buy $RMTIBuy: $1.0 to $1.10
Target-1 - $1.60
Target-2 - $2.20
Target-3 - $3.50
SL: $0.83
ROXADUSTAT PRESENTS A NEW OPPORTUNITY FOR TRIFERIC
New anemia drug expected to transform treatment & change iron requirements for dialysis patients
Roxadustat is a new approach to treatment of the anemia of CKD
•A phys
RMTI - Long - Wedge BreakoutRockwell Medical - Possible wedge breakout.
Retest 1.86 / 2.05-new support levels
PT Range 2.47-2.57
Rockwell Medical, is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraP
Rockwell Medical, Inc. On alert Above 100ma BreakRockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is h
RMTI- Repeating Stirrup pattern-Long We see a repeating pattern here, will it repeat again? a series of HHs and LLs, Solid trendline with multiple touches. Risk of failure: Bear Market
I will most likely enter this trade on the next trading day after the open. Too good to resist, with a good r/r and a tight stop!
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of RMTI is 1.03 USD — it has decreased by −1.06% in the past 24 hours. Watch Rockwell Medical, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Rockwell Medical, Inc. stocks are traded under the ticker RMTI.
RMTI stock has fallen by −5.64% compared to the previous week, the month change is a −42.75% fall, over the last year Rockwell Medical, Inc. has showed a −30.41% decrease.
We've gathered analysts' opinions on Rockwell Medical, Inc. future price: according to them, RMTI price has a max estimate of 5.00 USD and a min estimate of 3.00 USD. Watch RMTI chart and read a more detailed Rockwell Medical, Inc. stock forecast: see what analysts think of Rockwell Medical, Inc. and suggest that you do with its stocks.
RMTI reached its all-time high on Jul 17, 2015 with the price of 207.92 USD, and its all-time low was 0.84 USD and was reached on Nov 8, 2022. View more price dynamics on RMTI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RMTI stock is 5.00% volatile and has beta coefficient of 2.33. Track Rockwell Medical, Inc. stock price on the chart and check out the list of the most volatile stocks — is Rockwell Medical, Inc. there?
Today Rockwell Medical, Inc. has the market capitalization of 35.20 M, it has decreased by −6.31% over the last week.
Yes, you can track Rockwell Medical, Inc. financials in yearly and quarterly reports right on TradingView.
Rockwell Medical, Inc. is going to release the next earnings report on May 12, 2025. Keep track of upcoming events with our Earnings Calendar.
RMTI earnings for the last quarter are −0.02 USD per share, whereas the estimation was 0.0033 USD resulting in a −700.06% surprise. The estimated earnings for the next quarter are −0.043 USD per share. See more details about Rockwell Medical, Inc. earnings.
Rockwell Medical, Inc. revenue for the last quarter amounts to 24.66 M USD, despite the estimated figure of 23.50 M USD. In the next quarter, revenue is expected to reach 18.34 M USD.
RMTI net income for the last quarter is −755.00 K USD, while the quarter before that showed 1.43 M USD of net income which accounts for −152.76% change. Track more Rockwell Medical, Inc. financial stats to get the full picture.
No, RMTI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 17, 2025, the company has 244 employees. See our rating of the largest employees — is Rockwell Medical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Rockwell Medical, Inc. EBITDA is 2.79 M USD, and current EBITDA margin is 2.75%. See more stats in Rockwell Medical, Inc. financial statements.
Like other stocks, RMTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rockwell Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rockwell Medical, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rockwell Medical, Inc. stock shows the sell signal. See more of Rockwell Medical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.